A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population

Peggy Sekula, Oemer Necmi Goek, Lydia Quaye, Clara Barrios, Andrew S. Levey, Werner Römisch-Margl, Cristina Menni, Idil Yet, Christian Gieger, Lesley A. Inker, Jerzy Adamski, Wolfram Gronwald, Thomas Illig, Katja Dettmer, Jan Krumsiek, Peter J. Oefner, Ana M. Valdes, Christa Meisinger, Josef Coresh, Tim D. Spector & 4 others Karsten Suhre, Karsten Suhre, Gabi Kastenmüller, Anna Köttgen

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Small molecules are extensively metabolized and cleared by the kidney. Changes in serum metabolite concentrations may result from impaired kidney function and can be used to estimate filtration (e.g., the established marker creatinine) or may precede and potentially contribute to CKD development. Here, we applied a nontargeted metabolomics approach using gas and liquid chromatography coupled to mass spectrometry to quantify 493 small molecules in human serum. The associations of these molecules with GFR estimated on the basis of creatinine (eGFRcr) and cystatin C levels were assessed in ≤1735 participants in the KORA F4 study, followed by replication in 1164 individuals in the TwinsUK registry. After correction for multiple testing, 54 replicated metabolites significantly associated with eGFRcr, and six of these showed pairwise correlation (r≥0.50) with established kidney function measures: C-mannosyltryptophan, pseudouridine, N-acetylalanine, erythronate, myo-inositol, and N-acetylcarnosine. Higher C-mannosyltryptophan, pseudouridine, and O-sulfo-L-tyrosine concentrations associated with incident CKD (eGFRcr <60 ml/min per 1.73 m(2)) in the KORA F4 study. In contrast with serum creatinine, C-mannosyltryptophan and pseudouridine concentrations showed little dependence on sex. Furthermore, correlation with measured GFR in 200 participants in the AASK study was 0.78 for both C-mannosyltryptophan and pseudouridine concentration, and highly significant associations of both metabolites with incident ESRD disappeared upon adjustment for measured GFR. Thus, these molecules may be alternative or complementary markers of kidney function. In conclusion, our study provides a comprehensive list of kidney function-associated metabolites and highlights potential novel filtration markers that may help to improve the estimation of GFR.

Original languageEnglish
Pages (from-to)1175-1188
Number of pages14
JournalJournal of the American Society of Nephrology : JASN
Volume27
Issue number4
DOIs
Publication statusPublished - 1 Apr 2016
Externally publishedYes

Fingerprint

Pseudouridine
Metabolome
Kidney Diseases
Kidney
Creatinine
Population
Serum
Cystatin C
Metabolomics
Inositol
Gas Chromatography
Chronic Kidney Failure
Tyrosine
Registries
Mass Spectrometry

Keywords

  • CKD
  • epidemiology
  • GFR
  • metabolism
  • outcomes

ASJC Scopus subject areas

  • Nephrology

Cite this

Sekula, P., Goek, O. N., Quaye, L., Barrios, C., Levey, A. S., Römisch-Margl, W., ... Köttgen, A. (2016). A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population. Journal of the American Society of Nephrology : JASN, 27(4), 1175-1188. https://doi.org/10.1681/ASN.2014111099

A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population. / Sekula, Peggy; Goek, Oemer Necmi; Quaye, Lydia; Barrios, Clara; Levey, Andrew S.; Römisch-Margl, Werner; Menni, Cristina; Yet, Idil; Gieger, Christian; Inker, Lesley A.; Adamski, Jerzy; Gronwald, Wolfram; Illig, Thomas; Dettmer, Katja; Krumsiek, Jan; Oefner, Peter J.; Valdes, Ana M.; Meisinger, Christa; Coresh, Josef; Spector, Tim D.; Suhre, Karsten; Suhre, Karsten; Kastenmüller, Gabi; Köttgen, Anna.

In: Journal of the American Society of Nephrology : JASN, Vol. 27, No. 4, 01.04.2016, p. 1175-1188.

Research output: Contribution to journalArticle

Sekula, P, Goek, ON, Quaye, L, Barrios, C, Levey, AS, Römisch-Margl, W, Menni, C, Yet, I, Gieger, C, Inker, LA, Adamski, J, Gronwald, W, Illig, T, Dettmer, K, Krumsiek, J, Oefner, PJ, Valdes, AM, Meisinger, C, Coresh, J, Spector, TD, Suhre, K, Suhre, K, Kastenmüller, G & Köttgen, A 2016, 'A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population', Journal of the American Society of Nephrology : JASN, vol. 27, no. 4, pp. 1175-1188. https://doi.org/10.1681/ASN.2014111099
Sekula, Peggy ; Goek, Oemer Necmi ; Quaye, Lydia ; Barrios, Clara ; Levey, Andrew S. ; Römisch-Margl, Werner ; Menni, Cristina ; Yet, Idil ; Gieger, Christian ; Inker, Lesley A. ; Adamski, Jerzy ; Gronwald, Wolfram ; Illig, Thomas ; Dettmer, Katja ; Krumsiek, Jan ; Oefner, Peter J. ; Valdes, Ana M. ; Meisinger, Christa ; Coresh, Josef ; Spector, Tim D. ; Suhre, Karsten ; Suhre, Karsten ; Kastenmüller, Gabi ; Köttgen, Anna. / A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population. In: Journal of the American Society of Nephrology : JASN. 2016 ; Vol. 27, No. 4. pp. 1175-1188.
@article{fcb01c9bcec541429a2506e352113c2b,
title = "A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population",
abstract = "Small molecules are extensively metabolized and cleared by the kidney. Changes in serum metabolite concentrations may result from impaired kidney function and can be used to estimate filtration (e.g., the established marker creatinine) or may precede and potentially contribute to CKD development. Here, we applied a nontargeted metabolomics approach using gas and liquid chromatography coupled to mass spectrometry to quantify 493 small molecules in human serum. The associations of these molecules with GFR estimated on the basis of creatinine (eGFRcr) and cystatin C levels were assessed in ≤1735 participants in the KORA F4 study, followed by replication in 1164 individuals in the TwinsUK registry. After correction for multiple testing, 54 replicated metabolites significantly associated with eGFRcr, and six of these showed pairwise correlation (r≥0.50) with established kidney function measures: C-mannosyltryptophan, pseudouridine, N-acetylalanine, erythronate, myo-inositol, and N-acetylcarnosine. Higher C-mannosyltryptophan, pseudouridine, and O-sulfo-L-tyrosine concentrations associated with incident CKD (eGFRcr <60 ml/min per 1.73 m(2)) in the KORA F4 study. In contrast with serum creatinine, C-mannosyltryptophan and pseudouridine concentrations showed little dependence on sex. Furthermore, correlation with measured GFR in 200 participants in the AASK study was 0.78 for both C-mannosyltryptophan and pseudouridine concentration, and highly significant associations of both metabolites with incident ESRD disappeared upon adjustment for measured GFR. Thus, these molecules may be alternative or complementary markers of kidney function. In conclusion, our study provides a comprehensive list of kidney function-associated metabolites and highlights potential novel filtration markers that may help to improve the estimation of GFR.",
keywords = "CKD, epidemiology, GFR, metabolism, outcomes",
author = "Peggy Sekula and Goek, {Oemer Necmi} and Lydia Quaye and Clara Barrios and Levey, {Andrew S.} and Werner R{\"o}misch-Margl and Cristina Menni and Idil Yet and Christian Gieger and Inker, {Lesley A.} and Jerzy Adamski and Wolfram Gronwald and Thomas Illig and Katja Dettmer and Jan Krumsiek and Oefner, {Peter J.} and Valdes, {Ana M.} and Christa Meisinger and Josef Coresh and Spector, {Tim D.} and Karsten Suhre and Karsten Suhre and Gabi Kastenm{\"u}ller and Anna K{\"o}ttgen",
year = "2016",
month = "4",
day = "1",
doi = "10.1681/ASN.2014111099",
language = "English",
volume = "27",
pages = "1175--1188",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "4",

}

TY - JOUR

T1 - A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population

AU - Sekula, Peggy

AU - Goek, Oemer Necmi

AU - Quaye, Lydia

AU - Barrios, Clara

AU - Levey, Andrew S.

AU - Römisch-Margl, Werner

AU - Menni, Cristina

AU - Yet, Idil

AU - Gieger, Christian

AU - Inker, Lesley A.

AU - Adamski, Jerzy

AU - Gronwald, Wolfram

AU - Illig, Thomas

AU - Dettmer, Katja

AU - Krumsiek, Jan

AU - Oefner, Peter J.

AU - Valdes, Ana M.

AU - Meisinger, Christa

AU - Coresh, Josef

AU - Spector, Tim D.

AU - Suhre, Karsten

AU - Suhre, Karsten

AU - Kastenmüller, Gabi

AU - Köttgen, Anna

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Small molecules are extensively metabolized and cleared by the kidney. Changes in serum metabolite concentrations may result from impaired kidney function and can be used to estimate filtration (e.g., the established marker creatinine) or may precede and potentially contribute to CKD development. Here, we applied a nontargeted metabolomics approach using gas and liquid chromatography coupled to mass spectrometry to quantify 493 small molecules in human serum. The associations of these molecules with GFR estimated on the basis of creatinine (eGFRcr) and cystatin C levels were assessed in ≤1735 participants in the KORA F4 study, followed by replication in 1164 individuals in the TwinsUK registry. After correction for multiple testing, 54 replicated metabolites significantly associated with eGFRcr, and six of these showed pairwise correlation (r≥0.50) with established kidney function measures: C-mannosyltryptophan, pseudouridine, N-acetylalanine, erythronate, myo-inositol, and N-acetylcarnosine. Higher C-mannosyltryptophan, pseudouridine, and O-sulfo-L-tyrosine concentrations associated with incident CKD (eGFRcr <60 ml/min per 1.73 m(2)) in the KORA F4 study. In contrast with serum creatinine, C-mannosyltryptophan and pseudouridine concentrations showed little dependence on sex. Furthermore, correlation with measured GFR in 200 participants in the AASK study was 0.78 for both C-mannosyltryptophan and pseudouridine concentration, and highly significant associations of both metabolites with incident ESRD disappeared upon adjustment for measured GFR. Thus, these molecules may be alternative or complementary markers of kidney function. In conclusion, our study provides a comprehensive list of kidney function-associated metabolites and highlights potential novel filtration markers that may help to improve the estimation of GFR.

AB - Small molecules are extensively metabolized and cleared by the kidney. Changes in serum metabolite concentrations may result from impaired kidney function and can be used to estimate filtration (e.g., the established marker creatinine) or may precede and potentially contribute to CKD development. Here, we applied a nontargeted metabolomics approach using gas and liquid chromatography coupled to mass spectrometry to quantify 493 small molecules in human serum. The associations of these molecules with GFR estimated on the basis of creatinine (eGFRcr) and cystatin C levels were assessed in ≤1735 participants in the KORA F4 study, followed by replication in 1164 individuals in the TwinsUK registry. After correction for multiple testing, 54 replicated metabolites significantly associated with eGFRcr, and six of these showed pairwise correlation (r≥0.50) with established kidney function measures: C-mannosyltryptophan, pseudouridine, N-acetylalanine, erythronate, myo-inositol, and N-acetylcarnosine. Higher C-mannosyltryptophan, pseudouridine, and O-sulfo-L-tyrosine concentrations associated with incident CKD (eGFRcr <60 ml/min per 1.73 m(2)) in the KORA F4 study. In contrast with serum creatinine, C-mannosyltryptophan and pseudouridine concentrations showed little dependence on sex. Furthermore, correlation with measured GFR in 200 participants in the AASK study was 0.78 for both C-mannosyltryptophan and pseudouridine concentration, and highly significant associations of both metabolites with incident ESRD disappeared upon adjustment for measured GFR. Thus, these molecules may be alternative or complementary markers of kidney function. In conclusion, our study provides a comprehensive list of kidney function-associated metabolites and highlights potential novel filtration markers that may help to improve the estimation of GFR.

KW - CKD

KW - epidemiology

KW - GFR

KW - metabolism

KW - outcomes

UR - http://www.scopus.com/inward/record.url?scp=85017080584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017080584&partnerID=8YFLogxK

U2 - 10.1681/ASN.2014111099

DO - 10.1681/ASN.2014111099

M3 - Article

VL - 27

SP - 1175

EP - 1188

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 4

ER -